Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-07-001851
Filing Date
2007-03-26
Accepted
2007-03-26 17:28:38
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS, INC. b63761kae10vkza.htm 10-K/A 2055477
2 EX-23.1 CONSENT OF BDO SEIDMAN, LLP b63761kaexv23w1.txt EX-23.1 1216
3 EX-31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 302 b63761kaexv31w1.txt EX-31.1 3737
4 EX-31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 302 b63761kaexv31w2.txt EX-31.2 3670
5 EX-32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER SEC b63761kaexv32w1.txt EX-32.1 2683
6 GRAPHIC b63761kab6376102.gif GRAPHIC 9627
  Complete submission text file 0000950135-07-001851.txt   2081645
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 07719080
SIC: 2835 In Vitro & In Vivo Diagnostic Substances